drugset / Trial / NCT00005973

BMS-214662 in Treating Patients With Solid Tumors

NCT00005973

Phase 1 Completed 36 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of BMS-214662 in treating patients who have solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start
2000-04
Primary completion
2004-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-214662 Small molecule Intravenous